Senator Calls for Restoration of In-Person Dispensing for Abortion Pill

Senator Bill Cassidy from Louisiana is urging the Food and Drug Administration to bring back the requirement for in-person dispensing of the abortion pill. He expressed his concerns about safety to The Daily Signal.

“You don’t need a review to understand that if a woman has an ectopic pregnancy, there’s going to be a problem,” Cassidy stated. He also highlighted cases where individuals were pressured into taking the drug.

In April 2021, under President Biden, the requirement for in-person dispensing of abortion medications was lifted. This change came after a promise from the Trump administration to conduct a safety review of the abortion pill. However, over seven months later, the FDA is still in the “data acquisition phase,” according to Commissioner Dr. Marty Makary.

On Wednesday, the Senate Health, Education, Labor, and Pensions Committee, chaired by Cassidy, is set to hold a hearing focused on “protecting women from abortion drugs.” Cassidy hopes that the hearing will shed light on the issues surrounding the pill and how it affects both women and unborn children.

Cassidy pressed Makary to expedite the safety review, noting his dissatisfaction with the pace. “Get it done quickly because it was promised during confirmation hearings that it would be done,” he urged, adding that there is an expectation for timely progress.

“It seems like if they have a high priority to get something done—the data is already there,” he observed. “Sometimes you wonder about the source of the data, so why is it taking so long to acquire it?”

He voiced frustration over the approval of a second generic abortion drug by the Trump administration in October while the safety review remains ongoing. The FDA argued it had limited discretion under the law regarding generic drug approvals.

“The Biden administration didn’t feel the need to approve it, but this administration did,” Cassidy remarked, questioning the urgency given that it had taken four years under Biden’s watch.

He believes reinstating in-person requirements for mifepristone would safeguard women from being coerced into abortions. During the upcoming hearing, Louisiana Attorney General Liz Murrill will present two cases illustrating instances where women were forced to take abortion pills, resulting in the loss of their unborn children.

According to Cassidy, having an in-person consultation allows doctors to ensure that patients fully understand their decisions and are not being pressured into them. “We should care about that,” he emphasized.

Moreover, in-person visits also help identify situations that could make taking the abortion drug unsafe or even life-threatening, such as ectopic pregnancies or being further along in pregnancy than initially thought.

“This is a truly human story,” Cassidy said, stressing that it’s not simply about taking a pill without consequences. He acknowledged the serious implications for both the unborn child and the mother.

He concluded, “[We need to] understand that there are things we can do as a society to ensure she’s making informed choices and that health risks associated with the medication are minimized.”